ArticleFrontiers in cardiovascular medicine2026
Association between annular eccentricity and initial post-deployment paravalvular leak before corrective maneuvers in bicuspid aortic valve patients undergoing self-expanding transcatheter aortic valve replacement: a single-center retrospective study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The relationship between annular eccentricity and paravalvular leak (PVL) after transcatheter aortic valve replacement (TAVR) in bicuspid aortic valve (BAV) patients remains insufficiently defined, particularly for Chinese self-expanding valve platforms. This study evaluated the association between the CT-derived eccentricity index (EI) and initial post-deployment moderate-or-greater PVL after self-expanding TAVR in BAV patients. Methods: We retrospectively analyzed 194 consecutive BAV patients who underwent TAVR with the first-generation self-expanding VenusA valve. The primary endpoint was moderate-or-greater PVL assessed immediately after valve release and before corrective maneuvers such as post-dilatation. EI was measured by two independent observers with excellent interobserver agreement (ICC = 0.943). Multivariable logistic regression, ROC analysis, sensitivity analyses, and bootstrap internal validation were performed. NRI and IDI were analyzed as secondary measures of incremental information. Results: Initial post-deployment moderate-or-greater PVL occurred in 62 patients (32.0%). Although EI was modestly higher in patients with moderate-or-greater PVL than in those with no/mild PVL (median 0.23 [IQR 0.19-0.26] vs. 0.20 [0.17-0.25]; Conclusion: In BAV patients undergoing TAVR with the first-generation self-expanding VenusA valve, EI ≥0.19 was independently associated with initial post-deployment moderate-or-greater PVL, but its stand-alone and model-level discriminative performance were limited. EI should be considered a supplementary dimension in integrated preprocedural risk assessment rather than an isolated decision-making criterion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.